2,146
Views
3
CrossRef citations to date
0
Altmetric
Review

A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB)

, , , , , , , & show all
Pages 530-544 | Received 05 Apr 2023, Accepted 01 Jun 2023, Published online: 14 Jun 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Véronique Abitbol, Woo-Yun Sohn, Michael Horn & Marco Aurelio P. Safadi. (2023) Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review. Human Vaccines & Immunotherapeutics 19:2.
Read now

Articles from other publishers (2)

Pasquale Stefanizzi, Antonio Di Lorenzo, Andrea Martinelli, Lorenza Moscara, Paolo Stella, Domenica Ancona & Silvio Tafuri. (2023) Adverse events following immunization (AEFIs) with anti-meningococcus type B vaccine (4CMenB): Data of post-marketing active surveillance program. Apulia Region (Italy), 2019–2023. Vaccine 41:48, pages 7096-7102.
Crossref
Vanda Peixoto, Ana Carneiro, Fernanda Trigo, Mónica Vieira & Cristina Prudêncio. (2023) Paroxysmal Nocturnal Hemoglobinuria: A Case Report in a Pandemic Environment. Reports 6:3, pages 42.
Crossref